In Q3 earnings, Boston Scientific acknowledges Covid-19 headwinds
October 27, 2021 at 11:48 AM EDT
In the company's third-quarter earnings call on Wednesday morning, Boston Scientific Corp. CEO Michael Mahoney acknowledged the business effects of the Delta surge of Covid-19, but said he was optimistic that they were temporary setbacks.
